Nanobac Pharmaceuticals Inc (NNBP)
0.0000
USD |
OTCM |
May 01, 13:15
Price Chart
Key Stats
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 99.98% |
Profile
| Nanobac Pharmaceuticals Inc is a research-based, bio-lifescience company. The Company is primarily engaged in the discovery and development of products and services to improve peoples health through the detection and treatment of Calcifying Nanoparticles. |
| URL | http://www.nanobaclabs.com |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Nanobac Pharmaceuticals Inc is a research-based, bio-lifescience company. The Company is primarily engaged in the discovery and development of products and services to improve peoples health through the detection and treatment of Calcifying Nanoparticles. |
| URL | http://www.nanobaclabs.com |
| Investor Relations URL | N/A |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |